Syneos Health Schedules Second Quarter 2018 Earnings Call for Thursday, August 2, 2018

Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and CCO (Contract Commercial Organization), will release its second quarter 2018 financial results on Thursday, August 2, 2018, prior to its earnings call at 8:00 a.m. ET. 

Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please dial [phone] within the United States or [phone] outside the United States, approximately 15 minutes prior to the scheduled start time. The conference ID for the call is 2556819.

A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on August 2. In addition, an audio replay will be available for one week following the call and will be accessible by dialing [phone] within the United States or [phone] outside the United States. The replay ID is 2556819.

About Syneos HealthSyneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.

Investor Relations Contact:                              Ronnie Speight                                                    Vice President, Investor Relations                        [phone]                                                  [e-mail]                 

Press/Media Contact:Danielle DeForgeExecutive Director, External Communications+1 781 425 [e-mail]